The Impact of Sorafenib in Combination with Transarterial Chemoembolization on the Outcomes of Intermediate-Stage Hepatocellular Carcinoma

BACKGROUND: We investigated the treatment outcomes and hepatic reserve of transarterial chemoembolization (TACE)-refractory patients with recurrent advanced hepatocellular carcinoma (HCC) treated with TACE plus sorafenib. METHODS: Forty-one patients with intermediate-stage HCC defined as being TACE...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Asian Pac J Cancer Prev
Prif Awduron: Kaibori, Masaki, Matsushima, Hideyuki, Ishizaki, Morihiko, Kosaka, Hisashi, Matsui, Kosuke, Kariya, Shuji, Yoshii, Kengo, Sekimoto, Mitsugu
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: West Asia Organization for Cancer Prevention 2021
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8325117/
https://ncbi.nlm.nih.gov/pubmed/33906315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2021.22.4.1217
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg